beta
Trial Radar AI

Showing clinical trials for Obesity.

I can help you find nearby clinical trials and understand health conditions and treatments.
77 Results
Top 50 Showing
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Condition
Obesity
×
 
Keywords
Semaglutide
×
 
Intervention
GLP-1
×
 
Study Title
Status
Impact GLP-1 Agonists Following Bariatric NCT06132477
Recruiting
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists NCT07207148
Recruiting
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity (BETTER-GLP1) NCT07042672
Recruiting
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy NCT06903923
Recruiting
Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer NCT07314528
Not yet recruiting
Comparison of Body Composition Changes With Weight Loss Interventions (REFORM) NCT07115069
Recruiting
Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users (aGLP1-GUS) NCT06987669
Not yet recruiting
MAINTAIN (Mucosal AblatIoN Therapy After INcretins) NCT06734312
Recruiting
Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss. (OBA) NCT07411378
Not yet recruiting
Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients (GLP1-TASTE) NCT07229170
Not yet recruiting
Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment (PROBIO-GLP1) NCT07213323
Not yet recruiting
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity NCT07091500
Recruiting
Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions NCT06801015
Active, not recruiting
GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease NCT06546384
Not yet recruiting
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness NCT06487832
Recruiting
Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass (GLIMMER) NCT07272837
Not yet recruiting
Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock NCT07444073
Not yet recruiting
A Study of a Weight Loss Intervention in People With Endometrial Cancer NCT06751589
Recruiting
Semaglutide Treatment in Type 1 Diabetes (OBES1TY) NCT06909006
Not yet recruiting
Semaglutide 2.4mg for Low Responders After Bariatric Surgery (SEABAR) NCT06287307
Not yet recruiting
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected) NCT07225816
Recruiting
A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults (SOLUTION-Pilot) NCT07364175
Recruiting
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS) NCT07169136
Recruiting
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment NCT06411210
Recruiting
Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT) NCT07457424
Active, not recruiting
Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity (PLASTIC) NCT07021937
Not yet recruiting
Prevention of Progression of Prediabetes, Obesity and CV Risk (Pre-DM) NCT06446531
Recruiting
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects NCT06738979
Not yet recruiting
Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity (SEMAMOOD) NCT07136714
Recruiting
Effects of Semaglutide in HIV-Associated Lipohypertrophy NCT04019197
Active, not recruitingResults Posted
Bariatric Surgery Combined With GLP-1 Receptor Agonists Study (BS-GLP) NCT07336862
Recruiting
Genetics of the Acute Response to Oral Semaglutide (GAROS) NCT05340868
Recruiting
Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment NCT06069622
Recruiting
Pharmacogenetics of Response to GLP1R Agonists (PORT) NCT05071898
Recruiting
A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial) NCT06605703
Active, not recruiting
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss (PLATEAU) NCT07446998
Recruiting
CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users NCT06467604
Active, not recruiting
Young Adults With Early-onset Obesity Treated With Semaglutide (RESETTLE) NCT05574439
Recruiting
Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization. (SEQ) NCT07242534
Recruiting
Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults NCT06827002
Active, not recruiting
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes NCT07284979
Recruiting
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH) NCT07073417
Recruiting
Anti-obesity Pharmacotherapy and Inflammation NCT05756764
Active, not recruiting
Bariatric Surgery vs. Semaglutide vs. Tirzepatide NCT06803888
Recruiting
MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial NCT07505303
Not yet recruiting
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia NCT07107334
Recruiting
Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity NCT07293325
Recruiting
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis (SEMAPSO) NCT07401992
Recruiting
Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy NCT07244445
Recruiting
The Medically Reproducing Bariatric Surgery (MRB) II Study NCT06363747
Active, not recruiting